The Pradhan Mantri Jan Arogya Yojana PMJAY-Ayushman Bharat will have beneficiaries almost equal to the population of Canada, Mexico and the US combined together.
Indian govt officials last month skipped Turkish National Day celebrations in Delhi, in a message to Ankara following its support for Islamabad, particularly during Operation Sindoor.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
IF the Govt does something with good intention, so-called journalists in this mag will discover real and imaginary holes in the schemes. If Govt, does nothing, they will say, Govt is doing nothing.
Shoddy article. Author assumes and manipulates facts given in the links to suit the narrative. Opinions are being passed on as facts and facts are hiding somewhere in the corner.
1) Ayushman Bharat is yet to complete its first year. There is no credible data to support or refute author’s claims.
2) The claim of “63 million Indians fell into poverty each year” is from a six year old study by two researchers which is not only fails to define what poverty in this context is but also contradicts the findings of World Data Lab, Vienna according to which the number of poor in India (earn less than $1.90 daily) is little over 65 million and is decling steadily.
WB and UN have similar numbers. So how credible are the author’s numbers?
3) “Angioplasty costs down 8-18% post stent price cut, says study.” From this very article. How is that a bad thing?
4) “A global study has found a Made-in-India stent, Supraflex, clinically at par with Abbott’s Xience.” Please look up this sentence for more information.
Evidently, Indian made stents are just as good as Abbott’s and cost a fraction. So why the brouhaha?
Citing a study done by the stent manufacturer’s lobby group along with IQVIA only weakened the already shaky foundation of the article.
If the author is a reasercher then he is bad at his job. If he is writing this on someone else’s behalf then let the readers decide the validity of his claims and opinions based on better sourced information.
Very nicely argued. I agree with you. Its very easy to find favorable articles on a country like India which sadly ranks 184th out of 191 countries in terms of percentage of GDP expenditure on health. However, it shouldn’t be used to suite a particular agenda against a “specific person”.
@reply I don’t think that heathcare expediture per gdp is a metric India as a country should focus on. It is one of the umpteen “standards” thrown around as a one shoe fits all which is plain lazy and sometimes outright dangerous.
US spends more than 17% of its GDP on healthcare and still lacks universal healthcare coverage & lags behind on many key things. Thailand on the other hand spends just around 4% of its GDP and provides universal healthcare coverage.
IF the Govt does something with good intention, so-called journalists in this mag will discover real and imaginary holes in the schemes. If Govt, does nothing, they will say, Govt is doing nothing.
Shoddy article. Author assumes and manipulates facts given in the links to suit the narrative. Opinions are being passed on as facts and facts are hiding somewhere in the corner.
1) Ayushman Bharat is yet to complete its first year. There is no credible data to support or refute author’s claims.
2) The claim of “63 million Indians fell into poverty each year” is from a six year old study by two researchers which is not only fails to define what poverty in this context is but also contradicts the findings of World Data Lab, Vienna according to which the number of poor in India (earn less than $1.90 daily) is little over 65 million and is decling steadily.
WB and UN have similar numbers. So how credible are the author’s numbers?
3) “Angioplasty costs down 8-18% post stent price cut, says study.” From this very article. How is that a bad thing?
4) “A global study has found a Made-in-India stent, Supraflex, clinically at par with Abbott’s Xience.” Please look up this sentence for more information.
Evidently, Indian made stents are just as good as Abbott’s and cost a fraction. So why the brouhaha?
Citing a study done by the stent manufacturer’s lobby group along with IQVIA only weakened the already shaky foundation of the article.
If the author is a reasercher then he is bad at his job. If he is writing this on someone else’s behalf then let the readers decide the validity of his claims and opinions based on better sourced information.
Very nicely argued. I agree with you. Its very easy to find favorable articles on a country like India which sadly ranks 184th out of 191 countries in terms of percentage of GDP expenditure on health. However, it shouldn’t be used to suite a particular agenda against a “specific person”.
@reply I don’t think that heathcare expediture per gdp is a metric India as a country should focus on. It is one of the umpteen “standards” thrown around as a one shoe fits all which is plain lazy and sometimes outright dangerous.
US spends more than 17% of its GDP on healthcare and still lacks universal healthcare coverage & lags behind on many key things. Thailand on the other hand spends just around 4% of its GDP and provides universal healthcare coverage.